Search for a command to run...

Timestamps are as accurate as they can be but may be slightly off. We encourage you to listen to the full context.
This episode explores how Americans are rebuilding healthcare outside the traditional insurance system due to rising costs, limited access, and poor experiences. (00:33) Host Jay Rughani from a16z Health and Bio discusses with Nikhil Krishnan, founder of Out of Pocket, how consumer behavior and technology are converging to reconfigure U.S. healthcare. The conversation examines why insurance is losing its role as the default way people access care, with rising costs pushing more consumers toward cash-pay diagnostics, preventive care, and navigation services. (00:43) They analyze what this shift means for startups, AI-powered tools, regulation, and healthcare access as the industry continues moving beyond traditional insurance models.
Jay Rughani is a partner at Andreessen Horowitz (a16z) Health and Bio, where he focuses on investments in healthcare technology and biotechnology companies. He brings expertise in healthcare innovation and venture capital, helping to identify and support companies that are transforming how healthcare is delivered and accessed.
Nikhil Krishnan is the founder of Out of Pocket, a healthcare education company that helps people understand how healthcare works and navigate the system in practice. He has built a reputation as a thoughtful analyst of healthcare trends and policy, providing insights through his newsletter and content that make complex healthcare topics accessible to broader audiences.
The uninsured rate is projected to spike from the current 9.5% to 15%, reversing decades of progress from the Affordable Care Act. (04:57) This defection is driven by multiple factors: premium subsidies debates, rising costs in individual exchange markets, and small group insurance fragmentation as healthier employers exit the system. Krishnan notes that on health insurance subreddits, the question "should I just not get health insurance at all?" has become extremely common. For many people paying $600+ monthly premiums plus $5-6K deductibles, the rational choice may be to go uninsured and pay cash, especially for relatively healthy individuals who view insurance primarily as catastrophic coverage.
The shift toward cash-pay models is creating significant opportunities for startups focused on care navigation, transparent pricing, and direct-pay services. (24:28) Companies are emerging to help uninsured patients figure out where to go for care and whether issues are serious enough to warrant higher-cost medical practitioners. This includes novel contracting approaches with existing providers, similar to medical tourism but domestically focused. The Utah pilot allowing AI to prescribe medications for $4 instead of $150 office visits exemplifies how technology can deliver care at dramatically lower costs when insurance friction is removed.
Consumer appetite for monitoring and screening diagnostics is driving a new category of healthcare services outside traditional clinical guidelines. (27:58) People want agency in their healthcare and refuse to be told to "wait and see." This demand is particularly strong in cash-pay markets where consumers can escape the 10+ year lag between research evidence and clinical care guidelines. Examples include coronary calcium CT scans and other preventive screenings that patients are willing to pay for out-of-pocket, even when doctors say they don't need them. This represents a shift from reactive to proactive care models.
Healthcare employs 23 million Americans yet suffers from massive supply constraints, with 100+ million people lacking access to primary care and 40+ day wait times. (33:33) While AI can bridge this gap, Krishnan predicts significant populist resistance will emerge around job displacement fears, implementation challenges, and inevitable high-profile AI mistakes. The backlash will manifest through administrative workers fearing automation, physicians resisting AI mandates, and public reaction to AI errors. However, the fundamental question remains: how many people will AI help versus harm, and the median level of care improvement may justify the trade-offs.
State governments will increasingly clash with federal regulations on AI, insurance law, and public health guidelines, creating a patchwork of different rules across states. (40:54) This mirrors the Waymo rollout where different states have varying opinions on autonomous vehicles. While this creates compliance complexity favoring incumbents, it also enables valuable experimentation. States with large rural populations struggling with care access will likely embrace AI solutions more readily than those with competitive provider networks. The challenge lies in having proper data infrastructure to learn from these diverse experiments and scale successful models nationally.